Barclays Earnings Calls
| Release date | Oct 22, 2025 |
| EPS estimate | 0.116€ |
| EPS actual | 0.119€ |
| EPS Surprise | 2.76% |
| Revenue estimate | 7.992B |
| Revenue actual | 8.21B |
| Revenue Surprise | 2.72% |
| Release date | Jul 29, 2025 |
| EPS estimate | 0.124€ |
| EPS actual | 0.145€ |
| EPS Surprise | 17.04% |
| Revenue estimate | 8.097B |
| Revenue actual | 21.337B |
| Revenue Surprise | 163.51% |
| Release date | Apr 30, 2025 |
| EPS estimate | 0.140€ |
| EPS actual | 0.161€ |
| EPS Surprise | 15.63% |
| Revenue estimate | 8.215B |
| Revenue actual | 8.304B |
| Revenue Surprise | 1.08% |
| Release date | Feb 13, 2025 |
| EPS estimate | 0.0627€ |
| EPS actual | 0.0999€ |
| EPS Surprise | 59.37% |
| Revenue estimate | 8.743B |
| Revenue actual | 7.74B |
| Revenue Surprise | -11.47% |
Last 4 Quarters for Barclays
Below you can see how BCY.DE performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 13, 2025 |
| Price on release | 3.51€ |
| EPS estimate | 0.0627€ |
| EPS actual | 0.0999€ |
| EPS surprise | 59.37% |
| Date | Price |
|---|---|
| Feb 07, 2025 | 3.67€ |
| Feb 10, 2025 | 3.65€ |
| Feb 11, 2025 | 3.68€ |
| Feb 12, 2025 | 3.69€ |
| Feb 13, 2025 | 3.51€ |
| Feb 14, 2025 | 3.54€ |
| Feb 17, 2025 | 3.65€ |
| Feb 18, 2025 | 3.72€ |
| Feb 19, 2025 | 3.71€ |
| 4 days before | -4.25% |
| 4 days after | 5.64% |
| On release day | 0.797% |
| Change in period | 1.15% |
| Release date | Apr 30, 2025 |
| Price on release | 3.52€ |
| EPS estimate | 0.140€ |
| EPS actual | 0.161€ |
| EPS surprise | 15.63% |
| Date | Price |
|---|---|
| Apr 24, 2025 | 3.41€ |
| Apr 25, 2025 | 3.45€ |
| Apr 28, 2025 | 3.48€ |
| Apr 29, 2025 | 3.51€ |
| Apr 30, 2025 | 3.52€ |
| May 02, 2025 | 3.56€ |
| May 05, 2025 | 3.63€ |
| May 06, 2025 | 3.56€ |
| May 07, 2025 | 3.51€ |
| 4 days before | 3.23% |
| 4 days after | -0.426% |
| On release day | 1.08% |
| Change in period | 2.79% |
| Release date | Jul 29, 2025 |
| Price on release | 4.30€ |
| EPS estimate | 0.124€ |
| EPS actual | 0.145€ |
| EPS surprise | 17.04% |
| Date | Price |
|---|---|
| Jul 23, 2025 | 4.09€ |
| Jul 24, 2025 | 4.14€ |
| Jul 25, 2025 | 4.14€ |
| Jul 28, 2025 | 4.18€ |
| Jul 29, 2025 | 4.30€ |
| Jul 30, 2025 | 4.35€ |
| Jul 31, 2025 | 4.31€ |
| Aug 01, 2025 | 4.10€ |
| Aug 04, 2025 | 4.17€ |
| 4 days before | 5.13% |
| 4 days after | -3.02% |
| On release day | 1.05% |
| Change in period | 1.96% |
| Release date | Oct 22, 2025 |
| Price on release | 4.41€ |
| EPS estimate | 0.116€ |
| EPS actual | 0.119€ |
| EPS surprise | 2.76% |
| Date | Price |
|---|---|
| Oct 16, 2025 | 4.37€ |
| Oct 17, 2025 | 4.13€ |
| Oct 20, 2025 | 4.18€ |
| Oct 21, 2025 | 4.22€ |
| Oct 22, 2025 | 4.41€ |
| Oct 23, 2025 | 4.44€ |
| Oct 24, 2025 | 4.45€ |
| Oct 27, 2025 | 4.54€ |
| Oct 28, 2025 | 4.59€ |
| 4 days before | 0.92% |
| 4 days after | 4.09% |
| On release day | 0.795% |
| Change in period | 5.04% |
Barclays Earnings Call Transcript Summary of Q3 2025
Barclays delivered a strong Q3 2025 with top-line momentum and improving returns. Group income rose ~11% year-on-year to £7.2bn, TNAV per share increased to 392p, and Q3 RoTE was 10.6% (12.3% year-to-date). Management upgraded 2025 RoTE guidance to >11% and reaffirmed the >12% target for 2026. They raised group NII guidance slightly (now expected >£12.6bn for 2025) supported by UK lending momentum, operational progress in the U.S. Consumer Bank, and a larger/higher-yielding structural hedge (now £11.8bn locked for 2025–26 and average hedge duration increased to 3.5 years). Capital generation remains strong (CET1 14.1% pro forma 13.9% after a £500m share buyback brought forward), and management intends to announce buybacks quarterly subject to approvals. Efficiency delivery is ahead of plan (circa £500m gross savings for 2025 achieved one quarter early; £1.5bn of the £2bn 2026 target achieved so far). Key headwinds/notes: a £235m motor finance provision increased Q3 costs and reduced profits; group impairment charge was £632m (loan loss rate 57bp) including a circa £110m single-name charge in the investment bank and a lower-than-expected day-1 charge on the GM card acquisition. Business highlights: double-digit RoTE in all divisions; UK mortgages showing sustained net lending growth (5 quarters); UK Corporate lending and market share gains; Investment Bank improving income/RWA efficiency; U.S. Consumer Bank NIM progression to 11.5% and RoTE 13.5% with continued focus on reaching mid-teens longer term. Management will provide updated targets through to 2028 in February 2026.
Sign In
Buy BCY